online pharmacy, prescription drugs online



Drugs online research references











  • Cardiovascular effects of enflurane and asphyxia during long-term beta 1-adrenoceptor blockade.
  • Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation.
  • Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
  • Interaction between epinephrine and renal nerves in control of renin secretion rate.
  • Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
  • Sudden death related to advanced coronary atherosclerosis in mini-pigs: influence of some drugs.
  • Quality of life five years after myocardial infarction.
  • In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
  • Ten years of clinical experience with metoprolol.
  • Investigations in animal experiments into the influence of the beta-1-selective blocking agent metoprolol on the cardiovascular and metabolic side effects of the tocolytic fenoterol
  • Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats.
  • Complaints of cold extremities among patients on antihypertensive treatment.
  • Effects of chronic felodipine treatment on renal function and morphology in SHR.
  • Efficency of tocoylsis by fenoterol and fenoterol in combination with a beta-1-blocking compound
  • Increased shock-induced fighting with supersensitive beta-adrenergic receptors.
  • Capillary supercritical fluid chromatography of aliphatic amines. Studies on the selectivity and symmetry with three different columns using carbon dioxide or nitrous oxide as mobile phase.
  • Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets.
  • Role of sympathetic nerves for the stimulation of the renin system by angiotensin II receptor blockade.
  • Protection by blockers against human low density lipoprotein peroxidation induced by oxygen free radicals
  • Analysis of oxprenolol in formulations by high-performance liquid chromatography.
  • The release of serotonin from rat duodenal enterochromaffin cells by adrenoceptor agonists studied in vitro.
  • Maternal treatment with a cardioselective beta-blocking agent--consequences for the ovine fetus during intermittent asphyxia.
  • Characterization of functional beta-adrenoceptor subtypes in rabbit urinary bladder smooth muscle.
  • Isoproterenol and the genesis of reperfusion-induced arrhythmias in isolated rat heart: adrenoceptor or free radical-mediated mechanisms?
  • Use of cyclic boronates for GC/MS screening and quantitation of beta-adrenergic blockers and some bronchodilators.
  • The racemic metoprolol H2-antagonist interaction.
  • Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
  • A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release 'therapeutic drug' (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.
  • The modulation of head-twitch behaviour by drugs acting on beta-adrenoceptors: evidence for the involvement of both beta 1- and beta 2-adrenoceptors.
  • Effects of a cardiotonic agent, TA-064, on isolated canine cerebral, coronary, femoral, mesenteric, and renal arteries.
  • Myocardial metabolic and hemodynamic effects of a sustained intravenous infusion of nifedipine with and without metoprolol in patients with unstable angina.
  • Effect of beta-blocking agents and angiotensin II on isoproterenol-stimulated renin release from rat kidney slices.
  • Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.
  • Adrenoceptor blocking agents. Compounds related to metoprolol.
  • The influence of two histamine H2-receptor antagonists, cimetidine and ranitidine, on the plasma levels and clinical effect of nifedipine and metoprolol.
  • The treatment of essential hypertension in the hospital and in the office: is there a difference?
  • Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
  • Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
  • Effects of hypercholesterolemia on beta adrenoceptors in the rabbit heart.
  • Media hypertrophy in hypertensive coronary resistance vessels.
  • Regression of cardiac hypertrophy after therapy in animal hypertension.
  • The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol, and physostigmine in an animal model.
  • Observations in man of hypoglycaemia during selective and non-selective beta-blockade.
  • The relationship between casual and ambulatory blood pressure in essential hypertension: the influence of work, duration of hypertension and antihypertensive treatment.
  • Comparison of the hypotensive and metabolic effects of metoprolol therapy with a high fibre, low sodium, low fat diet in hypertensive type 2 diabetic subjects.
  • Regression of myocardial hypertrophy in hypertensives on chronic beta-receptor block
  • The beta 2-adrenoceptor agonists clenbuterol and salbutamol enhance the hypothermic action of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice by a central mechanism.
  • Selective labelling of beta 1-adrenoceptors in rabbit lung membranes by (-)3Hbisoprolol.
  • Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
  • Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
  • Effects of escapable and inescapable foot-shock on rat atrial beta-adrenoceptors.
  • Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes.
  • Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration.
  • Hemodynamic effects of inosine in combination with positive and negative inotropic drugs: studies on rats in vivo.
  • Reduction of catecholamine-induced cardiovascular malformations in the chick embryo with metoprolol.
  • Beta-adrenoceptor subtypes in the detrusor of guinea-pig urinary bladder.
  • Influence of adrenoceptor agonists and antagonists on fluid secretion in small bowel obstruction.
  • The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation.
  • Screening of beta-blockers in human serum by ion-pair chromatography and their identification as methyl or acetyl derivatives by gas chromatography-mass spectrometry.
  • Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.
  • Metoprolol-paroxetine interaction in human liver microsomes: stereoselective aspects and prediction of the in vivo interaction.
  • Effects of beta-adrenergic agonists on splanchnic vascular volume and cardiac output.
  • Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol.
  • Beta-adrenoceptor blocker intoxication: epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction.
  • Hypotensive effect of intracerebroventricular injection of norepinephrine and its modulation by alpha and beta adrenergic blockers in conscious rabbits.
  • Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment.
  • Hemodynamic effects of intravenous metoprolol in acute myocardial infarction: the role of anatomic subsets in predicting patient response.
  • Factors affecting iontophoretic mobility of metoprolol.
  • Cardiac autonomic blockade in sinus disease and indication for a pacemaker
  • The effect of metoprolol on intra-ocular pressure in glaucoma. A pilot study.
  • Beta 1-adrenergic mechanism is involved in stress-induced increase in arousal.
  • Silent myocardial ischemia--risk for sports in coronary groups?
  • Effects of dobutamine on isolated canine cerebral, coronary, mesenteric, and renal arteries.
  • Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
  • Increase in glucose and lactate output and perfusion resistance by stimulation of hepatic nerves in isolated perfused rat liver: role of alpha 1-, alpha 2-, beta 1- and beta 2-receptors.
  • Effects of metoprolol on left ventricular function in rats with myocardial infarction.
  • An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.
  • Treatment of life-threatening ventricular arrhythmias by a combination of antiarrhythmic drugs and right ventricular pacing.
  • Relaxing activity of two linear diterpenes from Cystoseira brachycarpa var. balearica on the contractions of intestinal preparations.
  • Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension.
  • Cardiac adaptation and its limitation in an experimental model of congestive heart failure.
  • Efficient high-performance liquid chromatographic assay for the simultaneous determination of metoprolol and two main metabolites in human urine by solid-phase extraction and fluorescence detection.
  • Rapid high-performance liquid chromatographic method for the measurement of the enantiomers of metoprolol in serum using a chiral stationary phase.
  • Simple high-performance liquid chromatographic method for the determination of ranitidine in human plasma.
  • Effect of 5-HT(1A) receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission.
  • The effect of metoprolol on left ventricular systolic and diastolic function in essential hypertension.
  • Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa
  • Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy.
  • Antagonistic effects of alpha-adrenoceptor blocking agents on arrhythmias, enzyme release, and myocardial necrosis in isolated rat hearts with coronary occlusion and reperfusion.
  • Instrumental color measurement: a method for judging the appearance of tablets.
  • Beta-adrenergic receptor mechanisms in rat parotid glands: activation by nerve stimulation and 3-isobutyl-1-methylxanthine.
  • Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs.
  • Metoprolol in diabetes mellitus: effect on glucose homeostasis.
  • Pronounced accumulation of metoprolol in ischemic myocardium after coronary venous retroinfusion.
  • Safety and tolerability of metoprolol OROS in hypertension treatment.
  • Attenuation of response to mental stress in patients with essential tremor treated with metoprolol.
  • Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog.
  • Selected ion monitoring of metoprolol and two metabolites in plasma and urine using deuterated internal standards.
  • Triiodothyronine-induced changes in function, metabolism and weight of the rat heart: effects of alpha- and beta-adrenergic blockade.
  • Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
  • Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium.
  • Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
  • Does chronic prenatal methadone exposure affect beta-receptor subtypes in placental, fetal and maternal brain homogenates?
  • Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients.
  • Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.
  • Effect of rifampicin on metoprolol and antipyrine kinetics.
  • Transdermal delivery of metoprolol. II: In-vitro skin permeation and bioavailability in hairless rats.
  • Administration of metoprolol in refractory and severe heart failure
  • Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.
  • Identification and characterisation of beta-adrenoceptors in guinea-pig skeletal muscle.
  • Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
  • Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthine.
  • Pharmacokinetics of metoprolol enantiomers following single and multiple administration of racemate in rat.
  • Chemical aspects of metoprolol metabolism. Asymmetric synthesis and absolute configuration of the 3-4-(1-hydroxy-2-methoxyethyl)phenoxy-1-(isopropylamino)-2-propanols , the diastereomeric benzylic hydroxylation metabolites.
  • Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.
  • Effects of long term metoprolol administration on the electrocardiogram of rats infected with T cruzi.
  • Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
  • Effect of intravenous metoprolol on left ventricular performance in Q-wave acute myocardial infarction.
  • Separation of enantiomeric amines by ion-pair chromatography.
  • Brain noradrenaline and anaesthesia: further characterization of the beta-receptor.
  • A fixed combination of metoprolol and hydrochlorothiazide for hypertension: a multi-centre study.
  • Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro.
  • Failure of intravenous metoprolol to limit acute myocardial infarct size in a nonreperfused porcine model.
  • Experimental study of metoprolol-induced side effects
  • Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients.
  • Time-dependent effect of metoprolol in middle-aged and old patients with angina
  • Absence of DNA damage in mice and rats given high doses of five beta-adrenergic blocking agents.
  • Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
  • Sympathetic nerves modify mitochondrial and capillary growth in normotensive and hypertensive rats.
  • The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats.
  • Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
  • Anti-hypertensive effect of metoprolol in spontaneously hypertensive rats.
  • Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney.
  • Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverine.
  • Adipose tissue and skeletal muscle blood flow during mental stress.
  • Evaluation of the effect of metoprolol on energy metabolism in the ischaemic myocardium in relation to regional myocardial blood flow.
  • Increased oral clearance of metoprolol in pregnancy.
  • Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment.
  • Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.
  • Action of calcium channel and beta-adrenergic blocking agents in bilayer lipid membranes.
  • Interaction of metoprolol and lidocaine on the ventricular fibrillation threshold in the anesthetized dog.
  • Functional importance of myocardial relaxation in patients with congestive heart failure.
  • Quantitative evaluation of myocardial injury induced by acute cerebral ischaemia and its prevention by beta 1-adrenergic blockade. An ultrastructural morphometry study.
  • Establishment and characterization of steroidogenic granulosa cells expressing beta(2)-adrenergic receptor: regulation of adrenodoxin and steroidogenic acute regulatory protein by adrenergic agents.
  • Renal selective N-acetyl-L-gamma-glutamyl prodrugs: studies on the selectivity of some model prodrugs.
  • Exaggerated sympathetic nervous system response to extended psychological stress in offspring of hypertensives.
  • Stimulatory effects of neuronally released norepinephrine on renin release from rat kidney cortical slices.
  • Efficacy of betaxolol in neuroleptic-induced akathisia.
  • Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.
  • Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
  • A role for N-methyl-D-aspartate receptors in norepinephrine-induced long-lasting potentiation in the dentate gyrus.
  • Effects of selective and non-selective beta 1-blockade on renin secretion in the isolated rat kidney.
  • Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol.
  • Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy.
  • Effects of adrenergic and cholinergic drugs on electrical and mechanical activities of the rat cauda epididymidis in vitro.
  • Pathway specificity of noradrenergic plasticity in the dentate gyrus.
  • Effect of CL 316,243, a novel beta 3-adrenoceptor agonist, on insulin secretion in perfused mouse pancreas.
  • Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
  • Noradrenergic control of ocular dominance plasticity in the visual cortex of dark-reared cats.
  • Simultaneous determination of propranolol or metoprolol in the presence of benzodiazepines in the plasma by gas chromatography.
  • Beta blockade for patients of mitral stenosis in sinus rhythm.
  • Circadian phase dependency of the effects of different beta-receptor blocking drugs on motor activity of rats. Importance of drug lipophilicity.
  • Simultaneous determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by liquid chromatography with a preliminary observation on metoprolol oxidation in Japanese subjects.
  • Assessment of optimal dose of diuretic associated with fixed dose of beta-blocking: a new experimental model based on multiple sampling of blood pressure performed by self-measurements.
  • Electrophysiologic effects of intravenous metoprolol.
  • Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
  • Responsiveness to dopamine of isolated epicardial coronary arteries from humans, monkeys, and dogs.
  • beta-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo.
  • The actions of tulobuterol on isolated preparations of gravid human myometrium.
  • The effects of metoprolol on systolic times in patients with systemic arterial hypertension. Polygraphic study
  • Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
  • Autonomic neural regulation of intact Purkinje system of dogs.
  • Cardiac antiischemic effect of metoprolol: role of beta-blockade within the ischemic region.
  • Effects of autonomic agents on the secretion of glycoproteins from the secretory cells of the major salivary glands in rats.
  • Beta-2 adrenoceptor control of the venous circulation in intact dogs.
  • Effects of footshock stress on the sensitivity of the isolated rat pacemaker to catecholamines.
  • Coupled-column chromatography on immobilized protein phases for direct separation and determination of drug enantiomers in plasma.
  • Metoprolol in the treatment of multifocal atrial tachycardia.
  • Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.
  • Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
  • Comparative clinical study of metoprolol and timolol
  • Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failure.
  • Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
  • Densitometric determination of metoprolol tartrate in pharmaceutical dosage forms.
  • Myocardial oxygen tension and capillary density in the isolated perfused rat heart during pharmacological intervention.
  • Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.
  • Hemodynamic responses to paraventricular nucleus disinhibition with bicuculline in conscious rats.
  • High-performance liquid chromatographic determination of metoprolol in plasma.
  • Effects of salbutamol upon performance on an operant screen for antidepressants.
  • An evaluation of the perioperative efficacy of selective beta 1-blockade in coronary surgery. Studies with a late preoperative dose of metoprolol.
  • Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
  • Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
  • Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
  • Aging and the pharmacokinetics and metabolism of metoprolol enantiomers in the rat.
  • A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
  • Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
  • Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.
  • Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.
  • Oxygen radical system in chronic infarcted rat heart: the effect of combined beta blockade and ACE inhibition.
  • CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.
  • Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers.
  • Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.
  • Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
  • Beta-adrenergic signalling and threshold adrenaline concentration for induction of fibrillation in the perfused heart pretreated with antihypertensive drugs.
  • Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
  • Stress-induced alteration in the lipolytic response to beta-adrenoceptor agonists in rat white adipocytes.
  • The relative bioavailability of metoprolol following oral and rectal administration to volunteers and patients.
  • TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa.
  • Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly.
  • Oxidative metabolism of cinnarizine in rat liver microsomes.
  • Enhanced pressor response to carotid occlusion in commNTS-lesioned rats: possible efferent mechanisms.
  • Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system.
  • Middle cerebral artery blood velocity during exercise with beta-1 adrenergic and unilateral stellate ganglion blockade in humans.
  • Screening and confirmatory analysis of beta-agonists, beta-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry.
  • Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats.
  • Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines.
  • Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta1-blocker treatment.
  • The Rational for the Use of A -Blockers in the Treatment of Congestive Heart Failure.
  • Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity.
  • Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects.
  • Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo.
  • Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
  • Enantiomeric separation of metoprolol and alpha-hydroxymetoprolol by liquid chromatography and fluorescence detection using a chiral stationary phase.
  • Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor.
  • Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries.
  • Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice.
  • Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium.
  • Scavenger effect of experimental and clinically used cardiovascular drugs.
  • Rx drugs
  • Adrenergic blocking agents and lipoprotein lipase activity.
  • The impact of specialists on prescribing by general practitioners.
  • beta-Adrenoceptor blockade enhances the anticonvulsant effect of glutamate receptor antagonists against maximal electroshock.
  • Detection of illegal clenbuterol use in calves using hair analysis. Application in meat quality control.
  • Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system.
  • Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
  • Atrial natriuretic peptide and the natriuresis due to acute beta-blockade in conscious hypertensive rats.
  • Ischemic and reperfusive release of the endogenous purines and its influence on the myocardial viability during beta-adrenergic blockade.
  • Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock.
  • Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.
  • Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.
  • Equal Efficacy and Improved Tolerability with 50 mg Controlled-Release Metoprolol Compared with 100 mg Conventional Metoprolol in Hypertensive Patients.
  • Screening drugs for metabolic stability using pulsed ultrafiltration mass spectrometry.
  • Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
  • Goteborg Metoprolol Trial: clinical observations.
  • Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats.
  • Influence of input rate on the stereospecific and nonstereospecific first pass metabolism and pharmacokinetics of metoprolol extended release formulations.
  • Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
  • The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation.
  • Novel metrics to compare dissolution profiles.
  • Effects of NaHCO3, alpha-, and beta-adrenergic blockade on albuminuria after swimming in splenectomized dogs.
  • Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
  • Beta-adrenoceptor blockers and the blood-brian barrier.
  • Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents.
  • Effects of cardioselective and nonselective beta-adrenergic antagonists on pulmonary mechanics.
  • Gastric, intestinal and colonic absorption of metoprolol in the rat.
  • Polyrotaxane approach for synthesis of continuous beds for capillary electrochromatography.
  • Adrenoceptors in avian and fish pigment cells.
  • Influence of beta-adrenoceptor antagonists on hemorrhage-induced cellular immune suppression.
  • Pharmacological blockade of the dive response: effects on heart rate and diving behaviour in the harbour seal (Phoca vitulina).
  • Clinical effectiveness of beta-adrenoblockers and their effects on copulative function in patients with hypertension
  • Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
  • Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation.
  • The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
  • Stability of neurohumoral effects of losartan combined with metoprolol in chronic cardiac low output
  • Patterns of antihypertensive agents use in 11,947 Colombian patients
  • Clinical application of combined beta 2-stimulation and beta 1-blockade in tocolysis
  • Enatiomeric separation of beta-blocking agents and analogs
  • Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
  • Enantiomeric separation of beta-blockers by HPLC using (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid as chiral stationary phase.
  • Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
  • Statin therapy restores sympathovagal balance in experimental heart failure.
  • Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
  • Stereoselective metabolism of metoprolol: enantioselectivity of alpha-hydroxymetoprolol in plasma and urine.
  • Administration of maximal or median doses of drugs in cardiovascular diseases?
  • Antihypertensive treatment and heart rate variability in diabetic patients: role of cardiac autonomic neuropathy.
  • Direct analysis of drugs in plasma by column-switching liquid chromatography-mass spectrometry using a methylcellulose-immobilized reversed-phase pretreatment column.
  • Long-term beta 1-selective adrenergic blockade and adrenergic receptors in human subcutaneous adipocytes.
  • Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
  • Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
  • Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension
  • Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes
  • Improvement of peak shape and separation performance of beta-blockers in conventional reversed-phase columns using solvent modifiers.
  • Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
  • Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
  • Rx drugs
  • pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
  • Evaluation of teicoplanin chiral stationary phases of 3.5 and 5 microm inside diameter silica microparticles by polar-organic mode capillary electrochromatography.
  • The effect of the beta 1-blocker metoprolol on cyclic 3',5'-adenosine monophosphate in various tissues during long-term tocolysis with fenoterol. Animal experiments on the question of the interactive effects of the principal and adverse effects of beta 2-mimetics with special regard to fetal cardioprotection
  • Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
  • Beta-adrenoceptor antagonists increase sinus arrhythmia, a vagotonic effect.
  • beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
  • Neuromedin U facilitates oxytocin release from the pituitary via beta adrenoceptors.
  • In Process Citation
  • In Process Citation
  • Drugs for preventing migraine headaches in children.
  • Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
  • Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
  • Action of agonists and antagonists on adrenergic receptors in isolated porcine coronary arteries.
  • Beta-blocker brain concentrations in man.
  • Strain rate acceleration yields a better index for evaluating left ventricular contractile function as compared with tissue velocity acceleration during isovolumic contraction time: an in vivo study.
  • Characterization of the antagonism with metoprolol, ICI 147,798, pindolol, mepindolol and bopindolol on the responses of the rat left atria to isoprenaline.
  • Results of pharmacoepidemiological study of arterial hypertension in Russia
  • Metoprolol in the treatment of essential hypertension
  • Synthesis and cardiovascular activity of metoprolol analogues.
  • Dosage of beta-adrenergic blockers after myocardial infarction.
  • Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells.
  • Alteration of growth and metabolic activity of cells in the presence of propranolol and metoprolol.
  • Rx drugs
  • Comparative pharmacology of human beta-adrenergic receptor subtypes-characterization of stably transfected receptors in CHO cells.
  • Analysis of urine samples containing cardiovascular drugs by micellar liquid chromatography with fluorimetric detection.
  • Ablation of postoperative "incisional" reentrant atrial tachycardia and flutter in children using the CARTO system
  • How Should Subgroup Analyses Affect Clinical Practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
  • Pheochromocytoma and pregnancy: a case report and review of anesthetic management: Pheochromocytome et grossesse. Expose d'un cas et revue de la demarche anesthesique.
  • Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
  • In Process Citation
  • Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
  • Left ventricular hypertrophy and its reversibility in young spontaneously hypertensive rats.
  • Effects of thoracic epidural anesthesia and adrenoceptor blockade on the cardiovascular response to dopamine in the dog.
  • Comparison of the effects of nicardipine and metoprolol on lipid and glycidic metabolism in hypertensive subjects.
  • Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450.
  • The effect of angiotensin converting enzyme inhibitors (ACE-I) and selective beta 1-antagonists on bronchial reactivity and the cough reflex in man.
  • The yohimbine-induced anticonflict effect in the rat, Part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms.
  • The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism.
  • Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
  • Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
  • Inhibition of purified human postheparin lipoprotein lipase by beta-adrenergic blockers in vitro.
  • Mechanism of reduced cardiac output during positive end-expiratory pressure in the dog.
  • Triphasic inotropic response of guinea-pig papillary muscle to murrayaquinone-A isolated from Rutaceae.
  • Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
  • Repeated swimming stress and responsiveness of the isolated rat pacemaker to the chronotropic effect of noradrenaline and isoprenaline: role of adrenal corticosteroids.
  • Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
  • Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
  • Hemodynamic effects of the cardioselective beta-blocking agent metoprolol in acute myocardial infarction. A 24-hour catheterization study.
  • Beta adrenergic influence on esophageal and colonic motility in man.
  • Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
  • Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
  • Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension.
  • Beta-adrenergic agonist- and prostaglandin-mediated regulation of cAMP levels in Ewing's sarcoma cells in culture.
  • Thoracic epidural anesthesia in conscious and anaesthetized rats. Effects on central haemodynamics compared to cardiac beta adrenoceptor and ganglionic blockade.
  • Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
  • A unique pressor response to isoprenaline in the pithed rat during triiodo-L-thyronine(T3)-induced hyperthyroidism.
  • The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women.
  • Reduction by acute restraint stress of noradrenaline sensitivity in the isolated pacemaker of the rat.
  • Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure.
  • Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
  • Effects of sympathetic nerve stimulation in the presence of specific adrenergic antagonists on Na, K, and Cl transport in perfused rat submandibular duct.
  • Effects of ranitidine on the disposition of metoprolol.
  • Evaluation of oxprenolol and metoprolol Oros systems in the dog: comparison of in vivo and in vitro drug release, and of drug absorption from duodenal and colonic infusion sites.
  • Natriuretic and hypertensive activities reside in a fragment of ACTH.
  • The influence of antihypertensive treatment on the renal arterial structure in spontaneously hypertensive rats. A morphometric study.
  • Frequency-dependent block of nerve conduction by beta-adrenergic blocking agents.
  • Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
  • Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test
  • Effects of beta-adrenoceptor agonists and antagonists on thyroid hormone secretion.
  • Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration.
  • Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
  • Comparison of metoprolol and propranolol in the treatment of akathisia.
  • Binding of beta-adrenoceptor antagonists to rat and rabbit lung: special reference to levobunolol.
  • Evidence, in uremic man, of the role of beta 2 adrenergic receptors in the secretion of parathyroid hormone and calcitonin
  • Effects of phenoxybenzamine, metoprolol, captopril, and meclofenamate on cardiovascular function in deoxycorticosterone acetate hypertensive Yucatan miniature swine.
  • Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit.
  • The effect of metoprolol on fenoterol-induced kidney function disorders
  • Suppression of atrial ectopy with intravenous metoprolol in chronic obstructive pulmonary disease patients.
  • Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol.
  • Comparison of metoprolol and verapamil in the treatment of angina pectoris.
  • Influence of the inorganic counterion on the chiral micellar electrokinetic separation of basic drugs using the surfactant N-dodecoxycarbonylvaline.
  • Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
  • Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
  • Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.
  • Metoprolol kinetics and dose response in hypertensive patients.
  • Response of the rat heart to catecholamines and thyroid hormones.
  • Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.
  • Beta-adrenoceptor activation stimulates, and phosphodiesterase inhibition potentiates, placental prorenin synthesis and release.
  • Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate.
  • Effect of dose of metoprolol on its elimination by isolated perfused rat liver in vitro.
  • Role of renal nerves for the expression of renin in adult rat kidney.
  • Synergistic effect of counterregulatory hormones during insulin-induced hypoglycemia in rats: participation of lipolysis and gluconeogenesis to hyperglycemia.
  • Studies on the antihypertensive effect of metoprolol in practice. Results of a cooperative study by 1296 general practitioners
  • Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
  • Comparison of nifedipine and metoprolol on collateral coronary blood flow in a swine model of chronic coronary obstruction and acute ischaemia during isoflurane anaesthesia.
  • Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
  • Prejunctional beta 1-adrenoceptors inhibit cholinergic transmission in canine bronchi.
  • Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A.
  • Effects of beta-adrenoceptor blockade on beta-adrenergic signal transduction in cardiomyopathic hamster (BIO 8262) hearts.
  • Rotating samples in FT-RAMAN spectrometers.
  • Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation.
  • Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
  • Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors.
  • Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations.
  • Ligand binding to the porcine adipose tissue beta-adrenergic receptor.
  • Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans.
  • Regulation of intracellular pH in rabbit cortical connecting tubule and cortical collecting duct.
  • Effects of various antihypertensive agents on lipid metabolism: alterations in the pattern of lipids synthesized from 14Coleate in rat liver in vitro.
  • Variability of beta-blocker pharmacokinetics in young volunteers.
  • The treatment of high blood pressure in the elderly: a multi-centre evaluation of a fixed combination of metoprolol and hydrochlorothiazide ("Co-Betaloc") in general practice.
  • Comparison of the anti-hypertensive response to beta-adrenoceptor blocking drugs in intact and adrenal-demedullated spontaneously hypertensive rats.
  • Beta-1 receptor is the predominant beta-adrenoreceptor on rat brown adipose tissue.
  • Adrenaline activation of prejunctional beta-adrenoceptors and hypertension.
  • Acute hypotensive effect of combined beta1-adrenoceptor blockade and beta2-adrenoceptor stimulation in spontaneously hypertensive rats (SHR).
  • Effect of norepinephrine, prenalterol and metoprolol on the histochemical localization of adenylate cyclase activity in the brown adipose tissue of newborn rat.
  • Additive intraocular pressure reducing effect of topical timolol during systemic beta-blockade.
  • Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
  • Effects of lidocaine, procainamide, metoprolol, digoxin and atropine on the conduction of premature ventricular beats in man.
  • Endothelial prostacyclin production, synergistic effect between adrenergic stimulating and blocking drugs.
  • Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
  • Intracoronary infusion of prostaglandin I2 attenuates arterial baroreflex control of heart rate in conscious dogs.
  • Drug interaction between propafenone and metoprolol.
  • Does sympathectomy or antihypertensive treatment affect the morphometry of basal cerebral arteries in spontaneously hypertensive rats?
  • The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.
  • Pharmacokinetic analysis of coronary venous retroinfusion: a comparison with anterograde coronary artery drug administration using metoprolol as a tracer.
  • Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.
  • Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
  • Effect of metoprolol on "non-specific" ST-segment and T-wave changes.
  • Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries.
  • Involvement of raphe-hippocampal serotonergic and septo-hippocampal cholinergic mechanisms in the penile erection induced by FR121196, a putative cognitive enhancer.
  • Roles of beta 1- and beta 2-adrenoceptors in the mechanism of halothane myocardial sensitization in dogs.
  • Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol.
  • Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
  • Antihypertensive drugs reduce noradrenaline-induced hypertrophy of cultured myocardial cells.
  • Long-term studies on regression of left ventricular hypertrophy.
  • Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.
  • Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
  • The force-interval relationship of the left ventricle: a quantitative description in patients with ischemic heart disease.
  • Vascular smooth muscle relaxation by alpha 1-adrenoceptor blocking action of denopamine in isolated rabbit aorta.
  • Propranolol has direct antithyroid activity: inhibition of iodide transport in cultured thyroid follicles.
  • Effect of epinephrine on renal potassium excretion in the isolated perfused rat kidney.
  • Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia.
  • Endothelial dysfunction in response to psychosocial stress in monkeys.
  • Effect of beta-blockade on regional left ventricular function in patients with dilated cardiomyopathy.
  • Adverse drug reaction reporting and retrospective phenotyping for oxidation polymorphism.
  • Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers.
  • Plasma catecholamines and cyclic AMP response during head-up tilt test in patients with neurocardiogenic (vasodepressor) syncope.
  • Hormonal and substrate responses during recovery from hypoglycaemia in man during beta 1-selective and non-selective beta-adrenergic blockade.
  • Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype-selective fashion.
  • On-line detection of reversible myocardial ischemic injury by measurement of myocardial electrical impedance.
  • Baroreflex control of heart rate and renin release in SHR following administration of felodipine, an antihypertensive Ca2+ antagonist.
  • The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
  • Beta adrenoceptors of human red blood cells, determination of their subtypes.
  • Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.
  • Interaction between bile salts and beta-adrenoceptor antagonists.
  • Influence of the beta-1 selective blocker, metoprolol, on the development of pulmonary edema in tocolytic therapy.
  • Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat.
  • Dietary obesity and weight cycling in rats: a model of stress-induced hypertension?
  • Inhibition of lymphocyte capping and transformation by propranolol and related compounds.
  • The surface activity and self-association of some beta-adrenoceptor blocking agents in aqueous solution.
  • Liquid chromatographic separation of the enantiomers of metoprolol and its alpha-hydroxy metabolite on Chiralcel OD for determination in plasma and urine.
  • Transient coronary stenosis associated with arrhythmia and ischemia 24 hours after reperfusion.
  • Effects of the serotonin-antagonist ketanserin on the function of ischaemic and normally perfused myocardium and modification by beta-1-blockade in anaesthetized normotensive dogs.
  • The neural control of the serotonin content in mammalian enterochromaffin cells.
  • Retrospective analysis showing less cardiac events in post-myocardial infarction patients treated with metoprolol. Secondary Prevention Group.
  • Metabolic actions of a single atenolol and metoprolol dose.
  • Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of beta-blocking agents.
  • The importance of lipid solubility and receptor selectivity of beta-adrenoceptor blocking drugs for the occurrence of symptoms and side-effects in out-patients.
  • Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia.
  • Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.
  • Graded physical loading in assessing the efficacy of hypotensive pharmacotherapy
  • Participation of beta 2-receptors in the control of rabbit ciliary epithelial permeability.
  • Conformational structure of some beta 1-blockers, their partitioning in lipid and the role of parasubstituents.
  • Direct enantioseparation of some beta-adrenergic blocking agents using impregnated thin-layer chromatography.
  • Quantitation of R- and S-propafenone and of the main metabolite in plasma.
  • Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
  • Influence of alpha stimulants and beta blockers on yohimbine toxicity.
  • alpha1-adrenergic stimulation induces early afterdepolarizations in ferret Purkinje fibers.
  • Cardiovascular response to stress: baroreflex resetting and hemodynamics.
  • Effects of antihypertensive agents propranolol, metoprolol, nadolol, prazosin, and chlorthalidone on ACAT activity in rabbit and rat aortas and on LCAT activity in human plasma in vitro.
  • Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure.
  • QT interval prolongation in acute myocardial infarction.
  • beta-Adrenergic receptor subtypes in melanophores of the marine gobies Tridentiger trigonocephalus and Chasmichthys gulosus.
  • Prophylaxis of supraventricular paroxysmal tachycardias on the basis of electrophysiologic examinations
  • Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations.
  • Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat.
  • Hemodynamic and reflex sympathetic control of transmural activation and rate of ventricular tachycardia in ischemic and hypertrophic ventricular myocardium of the dog.
  • Malignant vasovagal syncope: its diagnosis and therapeutic trial based on the orthostatism test (the tilt-table test)
  • Inhibition of 3H-dihydroalprenolol binding to rat cardiac membranes of various beta-blocking agents.
  • Influence of topical and systemic beta-blockers on tear production.
  • Effect of acute cardiac tamponade on left ventricular pressure-volume relations in anaesthetised dogs.
  • Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
  • Limitations of the stress test in the diagnosis of the sick sinus syndrome
  • Pharmacological evidence that alpha 1-adrenoceptors mediate metamorphosis of the Pacific oyster, Crassostrea gigas.
  • Cardiovascular effects of theophylline. Partial attenuation by beta-blockade.
  • Effects of metoprolol on the peripheral circulation in patients with peripheral vascular disease
  • Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
  • Beta adrenoceptors mediate the catecholamine-induced stimulation of oxytocin secretion from cultured bovine granulosa cells.
  • Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs
  • Coronary reperfusion by thrombolysis and early beta-adrenergic blockade in acute experimental myocardial infarction.
  • The cardiac hazard of tocolysis and antagonising possibilities. I. The haemodynamic situation of the patient during tocolysis/Protection of the myocardium by means of cardioselective beta-blockade. Experimental results
  • Migraine and beta blocker. An overview
  • Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.
  • Goteborg Metoprolol Trial: tolerance.
  • Dopexamine hydrochloride in the human heart: receptor binding and effects on cAMP generation.
  • The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
  • Inhibition by metoprolol of the antihypertensive effect of aspirin in young rats.
  • The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
  • Comparison of the effect of the beta1-blocking drugs atenolol and metoprolol on bronchial asthma.
  • Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.
  • Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation.
  • Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion
  • Keratinized epithelial transport of beta-blocking agents. II. Evaluation of barrier property of stratum corneum by using model lipid systems.
  • Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
  • Chronic beta-blockade transregulates inhibitory A1 adenosine and muscarinic M2 receptors of the adenylyl cyclase system.
  • Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
  • Differential effects of triiodothyronine on rat left and right ventricular function and the influence of metoprolol.
  • Effect of antihypertensive treatment on progression of incipient diabetic nephropathy.
  • Binding characteristics of 3H-CGP12177 to beta-adrenoceptors in rat myocardial membranes.
  • Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
  • Subtype-selective up-regulation of human saphenous vein beta 2-adrenoceptors by chronic beta-adrenoceptor antagonist treatment.
  • Determination of variability factors of arterial pressure using 3843 self-measurements of blood pressure in 34 active hypertensives
  • Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
  • Role of adrenoceptors in vasopressin, oxytocin and prolactin responses to conditioned fear stimuli in the rat.
  • Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
  • Regression of left ventricular hypertrophy in hypertensive patients: responses to exercise by antihypertensive treatment.
  • Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
  • Measurement of left ventricular maximal isovolumetric pressure in rats: effects of antihypertensive drugs and diabetes mellitus.
  • Autonomic control of ventricular tachycardia: direct effects of beta-adrenergic blockade in 24 hour old canine myocardial infarction.
  • Low clastogenic activity in vivo of the N-nitroso derivatives of 5 beta-adrenergic-blocking drugs proved to be potent genotoxins in vitro.
  • Homogeneous class of beta-1 adrenergic receptors in rat kidney. Identification by (+/-)-125 iodocyanopindolol binding.
  • Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.
  • Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?
  • Effects of the (+/-)-, (+)- and (-)-forms of propranolol, timolol and metoprolol on noradrenergic transmission in the rat isolated right ventricle.
  • Hemodynamic effects of once a day administration of combined chlorthalidone and metoprolol slow-release in essential hypertension.
  • Dissolution profile determination of a multicomponent product using a rapid liquid chromatographic analysis.
  • Metoprolol pharmacokinetics and the oral contraceptive pill.
  • Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone.
  • Effects of beta-blockade on atrial and atrioventricular nodal refractoriness, and atrial fibrillatory rate during atrial fibrillation in pigs.
  • Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine.
  • Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs.
  • Novel 'soft' beta-blockers as potential safe antiglaucoma agents.
  • Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6.
  • Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
  • Effects of propranolol on atherogenesis in the cholesterol-fed rabbit.
  • Use of 4-(N,N-dimethylaminosulphonyl)-7-fluoro-2,1,3-benzoxadiazole as a labelling reagent for peroxyoxalate chemiluminescence detection and its application to the determination of the beta-blocker metoprolol in serum by high-performance liquid chromatography.
  • Enantioselective determination of metoprolol in plasma by liquid chromatography on a silica-bonded alpha 1-acid glycoprotein column.
  • Heart rate-dependent atrioventricular nodal conduction and the effects of calcium channel blocking drugs: comparison of verapamil and nifedipine.
  • Characterization and autoradiographic distribution of the beta-adrenergic receptor in the rat lung.
  • Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
  • Within-patient comparisons between different anti-hypertensive drugs.
  • Coexistence of beta 1- and beta 2-adrenoceptors in the melanophore of the goby Tridentiger obscurus.
  • Evidence for a stimulatory beta-adrenergic component in the release of the ovulatory LH surge in pro-oestrous rats.
  • Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases
  • Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.
  • Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.
  • Existence of a beta3-adrenoceptro and its functional role in the human ureter.
  • Pharmacology of dextroamphetamine-induced cardiovascular malformations in the chick embryo.
  • Binding properties of beta-adrenergic receptors in early human fetal lung.
  • Pressor effect of beta-adrenergic receptor blocking drugs in spontaneously hypertensive rats treated with clonidine.
  • The effect of beta-adrenergic blockade in dilated cardiomyopathy--a questionnaire study in Japan.
  • Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
  • The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
  • Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum.
  • The effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine.
  • Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.
  • The effect of beta-adrenoceptor blocking agents on evolving myocardial necrosis in coronary ligated rats with and without reperfusion.
  • Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.
  • Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol.
  • Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias.
  • The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
  • The absorption of beta-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity.
  • Nature of the beta-adrenoreceptors in the tracheal smooth muscle of the adult pig.
  • Presence of beta-adrenoreceptors in the hypothalamus; their importance for the pressor response to hypothalamic stimulation.
  • Doping control for beta-adrenergic compounds through hair analysis.
  • The actions of the beta-adrenoceptor blocking agents propranolol and metoprolol in the maximally exercised horse.
  • Effect of an acute beta-adrenergic blockade on the relationship between ventilatory and plasma lactate threshold.
  • Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats.
  • Characterization of beta-adrenergic receptor subtypes in androgen-induced mouse kidney hypertrophy using a new high-affinity ligand, 125Iiodocyanopindolol.
  • Effects of selective beta-adrenoceptor antagonists on gastric ulceration in the rat.
  • Protective effects of different beta-blocking agents against electroshock lethality in mice.
  • No functional atypical beta-adrenergic receptors in human omental adipocytes.
  • Determination of beta-blocker drugs in pharmaceutical preparations by non-suppressed ion chromatography.
  • Out-patient use of beta-blocking agents--prescribing preferences of physicians in training.
  • Soft drugs. 7. Soft beta-blockers for systemic and ophthalmic use.
  • Inhibition of aconitine-induced mortality in the conscious rat: a screening test for antiarrhythmic drugs.
  • Determination of some beta-blockers as dabsyl derivatives by HPLC.
  • Protective effects of beta-blockers against 2,2'-azobis(2-amidinopropane)-dihydrochloride-induced damage.
  • A preliminary study of beta-cyclodextrin/metoprolol tartrate inclusion complex for potential enantiomeric separation.
  • Effect of the sympathetic activation and its inhibition on left ventricular mechanics in mitral prolapse. Echocardiographic study in 35 patients
  • Pre- and postjunctional beta-adrenoceptor mediated effects on transmitter release and effector response in the isolated rat portal vein.
  • Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
  • Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
  • Hemodynamic responses to beta-adrenergic blockade with metoprolol and pindolol after coronary artery bypass surgery.
  • A sustained increase in beta-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy.
  • Changes in lymphocyte beta-receptor density in patients with heart failure before and after metoprolol or captopril administration
  • The effect of beta-stimulation and beta-1-blockade on the motility of the upper urinary tract
  • Evidence that an atypical beta-adrenoceptor mediates the prejunctional inhibition of non-adrenergic non-cholinergic contraction in guinea-pig bronchi.
  • Plasma insulin levels and beta-adrenoceptor antagonists. The effects of cardioselective and non-cardioselective beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on basal insulin level and insulin level after glucose stimulation in normoglycemic dogs.
  • Polymorphic metabolism of beta-adrenoceptor antagonists.
  • Enantioselective assay of beta-receptor antagonists present in microdialysis and plasma samples of rats.
  • Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
  • Beta-1 and beta-2 adrenoceptors mediate smooth muscle relaxation in bovine isolated mesenteric lymphatics.
  • Food-induced reduction in bioavailability of atenolol.
  • Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
  • Effects of autonomic blockade on cardiac function at rest and during upright exercise in humans.
  • Local beta-adrenergic blockade does not reduce infarct size after coronary occlusion and reperfusion: a study of coronary venous retroinfusion of metoprolol.